Laser pen could measure skin cancer size without cutting
NCT ID NCT06384924
First seen May 13, 2026 · Last updated Jun 23, 2026 · Updated 8 times
Summary
This pilot study is testing whether a handheld laser probe, called Raman spectroscopy, can measure the size of skin cancer tumors. Twenty people with basal or squamous cell carcinoma who are already scheduled for brachytherapy will have their tumors scanned with the probe. The goal is to see if the laser can tell the difference between cancerous and healthy skin, which could help doctors plan treatment more precisely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stony Brook Hospital
RECRUITINGStony Brook, New York, 11794, United States
Contact Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Raman Spectroscopy handheld probe (device)
What this could lead to
If successful, this could lead to a non-invasive way to measure skin cancer tumor size, potentially improving treatment planning.
What could go wrong
This is a very small pilot study (20 people) testing feasibility only. The technique may not reliably distinguish cancerous from healthy tissue, and results may not apply to other skin cancers.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.